These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18086600)

  • 1. Acquired reactive perforating collagenosis induced by indinavir in 2 patients with HIV disease.
    Calista D; Morri M
    Eur J Dermatol; 2008; 18(1):84-5. PubMed ID: 18086600
    [No Abstract]   [Full Text] [Related]  

  • 2. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s.
    Henry K; Kitch D; Dube M; Zackin R; Parker RA; Sprecher D; Hammer S; Currier J;
    AIDS; 2004 Dec; 18(18):2434-7. PubMed ID: 15622323
    [No Abstract]   [Full Text] [Related]  

  • 3. Reactive perforating collagenosis during erlotinib therapy.
    Suzuki Y; Yamamoto T
    Acta Derm Venereol; 2012 Mar; 92(2):216-7. PubMed ID: 22101862
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir.
    Karmochkine M; Raguin G
    AIDS; 1998 Dec; 12(18):2499. PubMed ID: 9875590
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcome after coronary events in patients treated with HIV-protease inhibitors.
    Monsuez JJ; Gallet B; Escaut L; Vayre F; Charniot JC; Pulik M; Merad M; Minozzi C; Slama M; Weber S; Vittecoq D
    Eur Heart J; 2000 Dec; 21(24):2079-80. PubMed ID: 11102259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperlipidemia in patients with HIV infection treated with protease inhibitors].
    López García F; Mora Rufete A; Escolano Hortelano CM; Gutiérrez Rodero F
    Rev Clin Esp; 1999 Nov; 199(11):780-1. PubMed ID: 10638253
    [No Abstract]   [Full Text] [Related]  

  • 7. Indinavir and thrombocytopenia.
    Durand JM
    AIDS; 1999 Jan; 13(1):148-9. PubMed ID: 10207566
    [No Abstract]   [Full Text] [Related]  

  • 8. Adhesive capsulitis of the shoulder in human immunodeficiency virus-positive patients during highly active antiretroviral therapy.
    De Ponti A; Viganò MG; Taverna E; Sansone V
    J Shoulder Elbow Surg; 2006; 15(2):188-90. PubMed ID: 16517362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary necrosis associated with the HIV protease inhibitor indinavir.
    Dieleman JP; van der Feltz M; Bangma CH; Stricker BH; van der Ende ME
    Infection; 2001 Aug; 29(4):232-3. PubMed ID: 11545487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypertension and renal atrophy associated with indinavir.
    Cattelan AM; Trevenzoli M; Naso A; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 2000 Mar; 30(3):619-21. PubMed ID: 10722466
    [No Abstract]   [Full Text] [Related]  

  • 11. Indinavir--effect on sugar and insulin.
    TreatmentUpdate; 2001 Jun; 13(2):7-8. PubMed ID: 11570290
    [No Abstract]   [Full Text] [Related]  

  • 12. Relapsing blepharitis in patients under highly active antiretroviral therapy including indinavir.
    Lozano F; León EM; Mira JA; Corzo JE; Gómez-Mateos JM
    AIDS; 2004 Jan; 18(2):354-6. PubMed ID: 15075566
    [No Abstract]   [Full Text] [Related]  

  • 13. Unusual eruption in association with sorafenib: a case of acquired perforating dermatosis, reactive perforating collagenosis type.
    Lederhandler M; Beasley JM; Brinster NK; Nagler AR
    Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indinavir and bones: does thickness = strength?
    TreatmentUpdate; 2001 Jul; 13(3):6-8. PubMed ID: 11569990
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indinavir-associated tubulointerstitial renal disease].
    Gagnon RF; Mehio A; Iqbal S; Tsoukas CM
    Nephrol Ther; 2007 Dec; 3(7):461-2. PubMed ID: 18048001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor.
    Carr A; Cooper DA
    N Engl J Med; 1998 Oct; 339(18):1296. PubMed ID: 9791146
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part I.
    Boyle BA
    AIDS Read; 2001 Jul; 11(7):354-5, 359-61, 363. PubMed ID: 11494705
    [No Abstract]   [Full Text] [Related]  

  • 18. Vertebral fractures in AIDS patients within 6 months from highly active antiretroviral therapy initiation: two case reports.
    Gazzola L; Bini T; Pietrogrande L; Uziel L; Cicconi P; Casana M; Monforte Ad
    AIDS; 2008 May; 22(9):1094-7. PubMed ID: 18520358
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report.
    Giner V; Fernández C; Esteban MJ; Galindo MJ; Forner MJ; Guix J; Redón J
    Am J Hypertens; 2002 May; 15(5):465-7. PubMed ID: 12022250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paronychia with pyogenic granuloma in a child treated with indinavir: the retinoid-mediated side effect theory revisited.
    Sass JO; Jakob-Sölder B; Heitger A; Tzimas G; Sarcletti M
    Dermatology; 2000; 200(1):40-2. PubMed ID: 10681612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.